glp-1 method of action Current Insights, Advantages and Challenges Small Molecule Glucagon-like Peptide 1 Receptor Agonists: A Scoping Review Recent updates on GLP-1 agonists:

One example is the Jarisch-Herxheimer reaction, which may occur in those treated for syphilis or Lyme disease

Chronic SSRI stimulation of astrocytic 5-HT2B receptors change multiple gene expressions/editings and metabolism of glutamate, glucose and glycogen: a potential paradigm shift

Shahabuddin M, Fields I, Bulet P et al (1998) Plasmodium gallinaceum: differential killing of some mosquito stages of the parasite by insect defensin

Further information about our shots are provided below

The mechanistic rationale for the combination rests on the complementary and additive nature of GHRH receptor and ghrelin receptor activation with research demonstrating that simultaneous engagement of both receptor pathways produces greater GH release than either compound alone, while Ipamorelins selectivity profile minimizes cortisol and prolactin co-secretion that can confound GH axis research outcomes

A researcher or clinician who understands this will neither dismiss the peptide outright nor promote it as a proven therapy both errors ignore where the data actually sit